Breaking News
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
September 24, 2018 - ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma
September 24, 2018 - Public awareness of urological conditions found to be alarmingly low across Europe
September 24, 2018 - Fitter Folks Suffer Milder Strokes: Study
September 24, 2018 - Novel botulinum toxin compound relieves chronic pain
September 24, 2018 - CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents
September 24, 2018 - National Friendly’s private medical insurance is a hit with women living in the South East
September 24, 2018 - Academics receive prestigious awards for achievements in blood pressure research
September 24, 2018 - Obese pregnant women can restrict weight gain safely with proper nutrition guidance
September 24, 2018 - CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer
September 24, 2018 - China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma
September 24, 2018 - A new approach for finding Alzheimer’s treatments
September 24, 2018 - USC research uncovers previously unknown genetic risk factor for dementia
September 24, 2018 - Study examining mental health among students finds significant disparities in treatment across race
September 24, 2018 - Breakthrough discovery paves way for future test to identify drowsy drivers
September 24, 2018 - Transcatheter mitral-valve repair in patients with heart failure
September 24, 2018 - Study opens new avenues for treatment of Laing distal myopathy
September 24, 2018 - Stroke Facts | cdc.gov
September 24, 2018 - Sarcolipin tricks muscle cells into using more energy, burning fat
September 24, 2018 - Enrollment in opioid controlled substance agreement reduces primary care visits
September 24, 2018 - UTA researchers patent new smart seat cushion technology that helps prevent painful ulcers
September 24, 2018 - Second HPV-Related Primary Cancers Common in Survivors
September 24, 2018 - How a virus destabilizes the genome
September 24, 2018 - Old letters provide insight into Spanish flu pandemic horror
September 23, 2018 - Smart textile-based soft robotic exosuit helps wearers save energy and traverse difficult terrain
September 23, 2018 - New research hub to drive radical change in development and manufacturing of vaccines
September 23, 2018 - AHA: For Hispanics, Neighborhood May Be Key Factor in Heart Disease Risk
September 23, 2018 - Excessive airway nerves tied to more severe asthma symptoms, study finds
September 23, 2018 - Study highlights need to remain vigilant in maintaining key infection control processes
September 23, 2018 - Novel therapeutic strategy for blood vessel related disorders, such as cancer and retinopathy
September 23, 2018 - New naturally occurring antibiotic found effective against Mycobacterium tuberculosis
September 23, 2018 - First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma
September 23, 2018 - Removing tobacco product display from shops reduced number of children buying cigarettes
September 23, 2018 - Random fraction of specialized immune cells leads the charge in battling invaders
September 23, 2018 - Few minutes of sprinting exercise may be as effective as longer exercise sessions
September 23, 2018 - Researchers use neutrons to make first direct observations of water in lipid bilayers
September 23, 2018 - Researchers demonstrate pre-clinical success for universal flu vaccine in new paper
September 23, 2018 - Study reveals surprising gaps in some HIV medical providers’ knowledge of ACA
September 23, 2018 - Oxehealth secures European medical device accreditation for vital signs measurement software
September 23, 2018 - HTN Tx Intensification Common Upon Discharge in U.S. Vets
September 23, 2018 - Fibre can strengthen the intestinal barrier
September 23, 2018 - New platform examines infectious pathogens that may spread from animals to humans
September 23, 2018 - Demographers create detailed color map of population aging in Europe
September 23, 2018 - New type of fatty acid can slow down overreactive immune system
September 23, 2018 - Innovative procedure could provide breakthrough in treating early-stage lung cancer
September 23, 2018 - Research finds drop in number of measles cases in the EU/EEA since March 2018
Increasing biodefense risks posed by synthetic biology

Increasing biodefense risks posed by synthetic biology

image_pdfDownload PDFimage_print

A US Department of Defense commissioned study has found that there are several genetic-engineering tools that could be used to devise biological weapons in a short amount of time.

The extensive 221 page report says that tools itself could appear harmless and they could be put to good use such as creating genetically engineered disease-resistant plants or make genetically engineered personalized medicines etc. However several labs and companies are working towards making “synthetic-biology-enabled weapons.”

This latest report authored by 13 experts in the field, comes from the National Academies of Sciences and is the first that outlines national security threats from biological weapons using genetic engineering tools such as gene editing tool CRISPR. The report is titled, “Biodefense in the Age of Synthetic Biology” and was published yesterday.

CRISPR/Cas9 system for editing, regulating and targeting genomes. The Cas9 protein uses a gRNA (guide RNA) sequence to cut DNA at a complementary site. Molecular structure - RNA in red, DNA in yellow. Image Credit: ibreakstock / Shutterstock

CRISPR/Cas9 system for editing, regulating and targeting genomes. The Cas9 protein uses a gRNA (guide RNA) sequence to cut DNA at a complementary site. Molecular structure – RNA in red, DNA in yellow. Image Credit: ibreakstock / Shutterstock

Gigi Gronvall, a public health researcher at Johns Hopkins and a co-author of the report says that the risk expands when synthetic biology comes into play. This report, Gronvall says, is a framework that could evaluate the extent of risk posed by these tools and their misuse. Earlier in 2016 the US intelligence community had mentioned gene editing as one of the potential biological weapons of mass destruction. D. Christian Hassell, deputy assistant secretary of defense for chemical and biological defense, who was part of this new report explains that there are quite a few varied opinions regarding this from experts. This report, he said, was commissioned to gather all the opinions from the experts in one place. He added that at present the military does not view “synbio” as a major threat but is gearing up to prepare for this because soon it may pose a threat. Vaccines for example, against biological weapons such as altered viruses may take time to develop and early preparation is warranted.

The report outlines what could be done when synbio techniques are applied and the likelihood of populations that could be affected. Recreation and alteration of deadly viruses using genetic engineering is viewed as the greatest potential threat. Altering and making deadly bacteria more dangerous and resistant to treatment, creating harmful biochemicals at site of attack or within the body, altering human genome, altering human healthy bacterial microbiome, altering human immune systems, creating new pathogenic organisms are some of the concerns that have been expressed in the report. While some of these are of “highest concern”, some including creating new pathogenic organisms are of “lower concern” at the moment. The report says that some of these may appear to be too fantastic but with rapid advances in gene editing tools like CRISPR, it could not be entirely impossible. CRISPR could be used to modify human genomes to cause several diseases including cancer.

One of the scenarios in this report is when a terrorist group wants to use these altered and engineered viruses to different parts of the world and attempt to create a pandemic. The results could be deaths of over 150 million people within a year before a suitable vaccine could be made to fight the bio-weapon. The scenario showed that the response of the populations to the epidemic of an altered microbe would be similar to that when a natural pandemic such as influenza occurs.

The report was commissioned by the US military which itself remains one of the largest sponsors of synbio technologies. Experts believe that reports such as these could also trigger a “bio-weapons race” among nations. They explain that governments should keep a close eye on what is being achieved in this field just like they did on advances in physics and chemistry developing weapons of mass destruction during the Cold War times.

The report says that those very tools that could create these bio-weapons could be used to make effective and better vaccines and medicines to fight the synbio weapons. The techniques could be used to make diagnosis of these infections easy and improve disease surveillance and quarantine to prevent its spread.

Source:

National Academies of Sciences, Engineering, and Medicine. 2018. Biodefense in the Age of Synthetic Biology. Washington, DC: The National Academies Press. https://doi.org/10.17226/24890. https://www.nap.edu/catalog/24890/biodefense-in-the-age-of-synthetic-biology

Tagged with:

About author

Related Articles